Brief: Asit Biotech Selects First ASIT+™ Product For Treatment For Peanut Allergy
June 11 (Reuters) - ASIT BIOTECH SA ASIT.BR :
* ASIT BIOTECH SELECTS A FIRST ASIT+™ PRODUCT CANDIDATE FOR
THE
DEVELOPMENT OF A TREATMENT FOR PEANUT ALLERGY
* ASIT BIOTECH HAS DEVELOPED ITS FIRST PEPTIDE-BASED PRODUCT
CANDIDATE FOR A FOOD ALLERGY
* SELECTION OF THIS NEW PRODUCT CANDIDATE DEMONSTRATES
STRENGTH OF
ASIT+™ PLATFORM
Source text for Eikon: ID:nBw1kTK2Fa
Further company coverage: ASIT.BR
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 59 772 0920;))
Recent news on European Medical Solutions SA
See all newsBrief: DMS Imaging H1 EBITDA Rises To EUR 2.2 Million
Brief: DMS Imaging Announces Resumption Of Project To Transfer Its Listing Securities On Euronext Growth Market In Paris And Brussels
Brief: DMS Imagining Announces End Of Litigation With Thierry Legon
Brief: DMS Imaging Sees 2023 Revenue At 40 Million Euros
Brief: DMS Imaging Says Fujifilm Healthcare Italy Wins Tender For Its Radiology Tables